homologous recombination deficiency
IMBdx, AstraZeneca Expand Prostate Cancer Liquid Biopsy Partnership
Following an evaluation of the Korean firm's test, the two companies are partnering to increase awareness among clinicians and patients.
Illumina, Myriad Genetics Expand Partnership to Bring TSO 500 HRD Assay to US
The firms are creating a CDx alliance to help pursue HRD regulatory approvals for both the MyChoice HRD assay and a future clinical IVD test from Illumina.
End-Stage Ovarian Cancer Marked by Rampant Treatment Resistance, Multiple Clones
By profiling multiple tumors per patient, researchers found pronounced polyclonal disease and diverse resistance mechanisms in end-stage high-grade serous ovarian carcinoma.
Results from a homologous recombination deficiency assay concordance study led by Friends of Cancer Research were presented at the AMP annual meeting.
Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.